NCT04290156 (TRANS-IBD) is a NA clinical trial of joint visits in Inflammatory Bowel Diseases, sponsored by University of Pecs.

Who is sponsoring NCT04290156?

NCT04290156 is sponsored by University of Pecs.

What drugs are being tested in NCT04290156?

Interventions in NCT04290156: joint visits.

What condition does NCT04290156 study?

NCT04290156 studies Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis.

Is NCT04290156 still recruiting?

NCT04290156 is currently status unknown. Last updated 28 February 2020.

Last reviewed 2020-02-28 · How we verify

NCT04290156: TRANS-IBD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD)

Status unknown NA Last updated 28 February 2020

What this trial tests

NA trial testing joint visits in Inflammatory Bowel Diseases in 160 participants. Status unknown.

Timeline

1 April 2020

Primary endpoint
1 April 2024

1 November 2024

Quick facts

Lead sponsor	University of Pecs
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	160
Start date	1 April 2020
Primary completion	1 April 2024
Estimated completion	1 November 2024

Drugs / interventions tested

joint visits

Conditions studied

Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
Crohn's Disease — all drugs for Crohn's Disease →
Ulcerative Colitis — all drugs for Ulcerative Colitis →

Sponsor

University of Pecs

Who can join

Adults 16 to 17, any sex, with Inflammatory Bowel Diseases or Crohn's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inflammatory bowel diseases (IBD) are among the most common chronic illnesses diagnosed in childhood. Moving from the pediatric to the adult health care is a crucial phase, which can greatly affect adolescents' quality of life. According to the latest international guidelines, based in particular on expert opinions, the implementation of joint visits (involving both pediatric and adult gastroenterologists) are highly recommended during the transition period. This trial aims to prove the beneficial effect of the joint visits.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD).
Erős A, Dohos D, Veres G, Tárnok A, et al · · 2020 · cited 6× · PMID 33028560 · DOI 10.1136/bmjopen-2020-038410
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition.
Nardone OM, Martinelli M, de Sire R, Calabrese G, et al · · 2024 · cited 3× · PMID 38827647 · DOI 10.1177/17562848241241234

Verify or expand the search:

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting

Other University of Pecs trials

Trials by the same sponsor.

NCT07520877 — Effect of AED-optimized Telephone-assisted CPR Instructions on No-flow Time and Chest Compression Fraction · NA · recruiting
NCT05060731 — Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding · Phase 4 · not yet recruiting
NCT07101510 — V-CPR Under Special Circumstances · NA · completed
NCT07068503 — Study of Running Injuries and Treatment Habits in Romanian Speakers · not yet recruiting
NCT07044219 — The Effect of Chlorhexidine + Hyaluronic Acid on Postoperative Wound Healing After Lower Third Molar Removal · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04290156 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pecs
Last refreshed: 28 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04290156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing